Role of NMDA receptors in the trigeminal pathway, and the modulatory effect of magnesium in a model of rat temporomandibular joint arthritis

European Journal of Oral Sciences

Volumn 121, Issue 6, 2013, Pages 573-583

  Cavalcante, André L C ^a   Siqueira, Rafaelly M P ^a   Araujo, Joana C B ^a   Gondim, Delane V ^a   Ribeiro, Ronaldo A ^a   Quetz, Josiane S ^a   Havt, Alexandre ^a   Lima, Aldo A M ^a   Vale, Mariana L ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Magnesium; N methyl d aspartate receptor (NMDA R); NR3; Orofacial pain; Temporomandibular joint

Indexed keywords

CARRAGEENAN; MAGNESIUM; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE EXPRESSION; MAGNESIUM DEFICIENCY; MALE; METABOLISM; MOLECULAR GENETICS; N-METHYL-D-ASPARTATE RECEPTOR (NMDA-R); NOCICEPTIVE PAIN; NR3; OROFACIAL PAIN; OSTEOARTHRITIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; TIME; TRIGEMINAL NERVE; TRIGEMINAL NUCLEUS; WISTAR RAT;

MAGNESIUM; N-METHYL-D-ASPARTATE RECEPTOR (NMDA-R); NR3; OROFACIAL PAIN; TEMPOROMANDIBULAR JOINT;

ANALYSIS OF VARIANCE; ANIMALS; CARRAGEENAN; GENE EXPRESSION; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MOLECULAR SEQUENCE DATA; NOCICEPTIVE PAIN; OSTEOARTHRITIS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEMPOROMANDIBULAR JOINT DISORDERS; TIME FACTORS; TRIGEMINAL CAUDAL NUCLEUS; TRIGEMINAL NERVE;

EID: 84887381121     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/eos.12093     Document Type: Article

References (53)

1. Dahlstrom L, Carlsson GE. Temporomandibular disorders and oral health-related quality of life. A systematic review. Acta Odontol Scand 2010; 68: 80-85.
2. Hargreaves KM. Orofacial pain. Pain 2011; 152: S25-S32.
3. Britton NF, Chaplain MA, Skevington SM. The role of N-methyl- D-aspartate (NMDA) receptors in wind-up: a mathematical model. IMA J Math App Med Biol 1996; 13: 193-205.
4. Chen J, Lee CT, Errico SL, Becker KG, Freed WJ. Increases in expression of 14-3-3 eta and 14-3-3 zeta transcripts during neuroprotection induced by delta 9-tetrahydrocannabinol in AF5 cells. J Neurosci Res 2007; 85: 1724-1733.
5. Dickenson AH. A cure for wind-up: NMDA receptor antagonists as potential analgesics. Trends in Pharmacol Sci 1990; 11: 307-309.
6. Eide PK. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain 2000; 4: 5-15.
7. Parada CA, Luccarini P, Woda A. Effect of an NMDA receptor antagonist on the wind-up of neurons in the trigeminal oralis subnucleus. Brain Res 1997; 761: 313-320.
8. REN K. Wind-up and the NMDA receptor: from animal studies to humans. Pain 1994; 59: 157-158.
9. Begon S, Pickering G, Eschalier A, Mazur A, Rayssiguier Y, Dubray C. Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats. Br J Pharmacol 2001; 134: 1227-1236.
10. Bereiter DA, Bereiter DF. Morphine and NMDA receptor antagonism reduce c-fos expression in spinal trigeminal nucleus produced by acute injury to the TMJ region. Pain 2000; 85: 65-77.
11. Cairns BE, Svensson P, Wang K, Hupfeld S, Graven-Nielsen T, Sessle BJ, Berde CB, Arendt-Nielsen L. Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2003; 90: 2098-2105.
12. Davar G, Hama A, Deykin A, Vos B, MacIewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res 1991; 553: 327-330.
13. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neurophatic pain: a comparison of ketamine and magnesium chloride. Pain 1996; 64: 283-291.
14. Ivanusic JJ, Beaini D, Hatch RJ, Staikopoulos V, Sessle BJ, Jennings EA. Peripheral N-methyl-d-aspartate receptors contribute to mechanical hypersensitivity in a rat model of inflammatory temporomandibular joint pain. Eur J Pain 2011; 15: 179-185.
15. Liu Y, Zhang J. Recent development in NMDA receptors. Chin Med J 2000; 113: 948-956.
16. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg 2003; 97: 1108-1116.
17. Li J, McRoberts JA, Nie J, Ennes HS, Mayer EA. Electrophysiological characterization of N-methyl-D-aspartate receptors in rat dorsal root ganglia neurons. Pain 2004; 109: 443-452.
18. Jenkinson DH. The nature of the antagonism between calcium and magnesium ions at the neuromuscular junction. J Physiol 1957; 138: 434-444.
19. 2+ of N-methyl-D-aspartate-activated channels. Biophys J 1990; 57: 1085-1090.
20. Ren K, Dubner R. Central nervous system plasticity and persistent pain. J Orofac Pain 1999; 13: 155-163.
21. Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004; 2004: re16.
22. Michaelis EK. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 1998; 54: 369-415.
23. Miki K, Zhou QQ, Guo W, Guan Y, Terayama R, Dubner R, Ren K. Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation. J Neurophysiol 2002; 87: 750-760.
24. Denadai-Souza A, Camargo LL, Ribela MT, Keeble JE, Costa SK, Muscara MN. Participation of peripheral tachykinin NK1 receptors in the carrageenan-induced inflammation of the rat temporomandibular joint. Eur J Pain 2009; 13: 812-819.
25. Paxinos G, Huang XF. Atlas of the human brainstem. San Diego: Academic Press, 1995.
26. Pfaffl MW. A new mathematical model for relative quantification in realtime time RT-PCR. Nucleic Acids Res 2001; 29: e45.
27. 2+ deficiency induce a long-term sensitization of the central nociceptive pathways? Eur J Pharmacol 2003; 469: 65-69.
28. Feria M, Abad F, Sanchez A, Abreu P. Magnesium sulphate injected subcutaneously suppresses autotomy in peripherally deafferented rats. Pain 1993; 53: 287-293.
29. Begon S, Pickering G, Eschalier A, Dubray C. Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain Res 2000; 887: 436-439.
30. Hallak M. Effect of parenteral magnesium sulfate administration on excitatory amino acid receptors in the rat brain. Magnes Res 1998; 11: 117-131.
31. Wang S, Lim G, Mao J, Sung B, Mao J. Regulation of the trigeminal NR1 subunit expression induced by inflammation of the temporomandibular joint region in rats. Pain 2009; 141: 97-103.
32. Raymond LA, Tingley WG, Blackstone CD, Roche KW, Huganir RL. Glutamate receptor modulation by protein phosphorylation. J Physiol Paris 1994; 88: 181-192.
33. Ultenius C, Linderoth B, Meyerson BA, Wallin J. Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett 2006; 399: 85-90.
34. Da Silva LF, Walder RY, Davidson BL, Wilson SP, Sluka KA. Changes in expression of NMDA-NR1 receptor subunits in the rostral ventromedial medulla modulate pain behaviors. Pain 2010; 151: 155-161.
35. South SM, Kohno T, Kaspar BK, Hegarty D, Vissel B, Drake CT, Ohata M, Jenab S, Sailer AW, Malkmus S, Masuyama T, Horner P, Bogulavsky J, Gage FH, Yaksh TL, Woolf CJ, Heinemann SF, Inturrisi CE. A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. J Neurosci 2003; 23: 5031-5040.
36. Kus L, Sanderson JJ, Beitz AJ. N-methyl-D-aspartate R1 messenger RNA and [125I] MK-801 binding decrease in rat spinal cord after unilateral hind paw inflammation. Neuroscience 1995; 68: 159-165.
37. Mu Y, Otsuka T, Horton AC, Scott DB, Ehlers MD. Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors. Neuron 2003; 40: 581-594.
38. Waters KA, MacHaalani R. NMDA receptors in the developing brain and effects of noxious insults. Neurosignals 2004; 13: 162-174.
39. Yokoyama H, Kuroiwa H, Kasahara J, Araki T. Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine)-induced mouse model of Parkinson's disease. Acta Neurobiol Exp 2011; 71: 269-280.
40. Rondon LJ, Privat AM, Daulhac L, Davin N, Mazur A, Fialip J, Eschalier A, Courteix C. Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain. J Physiol 2010; 588: 4205-4215.
41. Fu L, Tang R, Bao N, Wang J, Ma H. Ketamine and propofol in combination induce neuroapoptosis and down-regulate the expression of N- methyl-D-aspartate glutamate receptor NR2B subunit in rat forebrain culture. Pharmazie 2011; 66: 771-776.
42. Loftis JM, Janowsky A. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 2003; 97: 55-85.
43. Ma QP, Hargreaves RJ. Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats. Neuroscience 2000; 101: 699-707.
44. Mihara Y, Egashira N, Sada H, Kawashiri T, Ushio S, Yano T, Ikesue H, Oishi R. Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats. Mol Pain 2011; 7: 8.
45. Cavara NA, Orth A, Hollmann M. Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors. BMC Neurosci 2009; 10: 32.
46. Henson MA, Roberts AC, Perez-Otano I, Philpot BD. Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol 2010; 91: 23-37.
47. Nakanishi N, Tu S, Shin Y, Cui J, Kurokawa T, Zhang D, Chen HS, Tong G, Lipton SA. Neuroprotection by the NR3A subunit of the NMDA receptor. J Neurosci 2009; 29: 5260-5265.
48. Matsuda K, Kamiya Y, Matsuda S, Yuzaki M. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Brain Res Mol Brain Res 2002; 100: 43-52.
49. Nishi M, Hinds H, Lu HP, Kawata M, Hayashi Y. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci 2001; 21: RC185.
50. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall J, Dikkes P, Conner DA, Rayudu PV, Cheung W, Chen HS, Lipton SA, Nakanishi N. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 1998; 393: 377-381.
51. Perez-Otano I, Schulteis CT, Contractor A, Lipton SA, Trimmer JS, Sucher NJ, Heinemann SF. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci 2001; 21: 1228-1237.
52. Sasaki YF, Rothe T, Premkumar LS, Das S, Cui J, Talantova MV, Wong HK, Gong X, Chan SF, Zhang D, Nakanishi N, Sucher NJ, Lipton SA. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol 2002; 87: 2052-2063.
53. German-Fattal M, Lecerf F, Sabbagh F, Maurois P, Durlach J, Bac P. Neuroprotective gene profile in the brain of magnesium-deficient mice. Biomed Pharmacother 2008; 62: 2064-2072.